Authors
Skryabin E.S., Khanaliev B.V., Maslennikov M.A., Marchak D.I.
Pirogov National Medical and Surgical Center, Moscow
Abstract
The review presents publications about prostatic artery ebmolization. Based on the analysis, the general principles and concepts of minimally invasive surgical treatment of patients with benign prostatic hyperplasia were formed, the main groups of options for the postoperative course and complications after this intervention were formed. The prognostic role of prostate hyperplasia volume is emphasized.
Keywords: embolization, prostate, benign prostatic hyperplasia.
References
1. Seldinger SI: Catheter replacement of the needle in percutaneous angiography. Acta Radiol. 1953; 39: 368-376.
2. Dotter CT, Judkins MP: Percutaneous transluminal treatment of arteriosclerotic obstruction. Radiology. 1965; 84: 631-643.
3. Gruntzig A, Hopff H: PerkutanRecanalisation chronischer arterieller Arterien-verschlus semiteinemneuen Dilatations-katheter: Modification der Dotter-Technik. Dtsch Med Wochenschr. 1974; 99: 2502-2505.
4. Stone GW. Bioresorbable vascular scaffolds: more different than alike? JACC CardiovascInterv. 2016; 9: 575-7.
5. Sheth RA, Sabir S, Krishnamurthy S, Avery RK, Zhang YS, Khademhosseini A, Oklu R. J. Endovascular Embolization by Transcatheter Delivery of Particles: Past, Present, and Future Funct. Biomater. 2017, 8: 12.
6. Dawbarn RHM, JAMA. J Interventional Radiology, Williams and Wilkins, Baltimore, MD. 1997; Am. Med. Assoc. 1904, 43: 0792.
7. Poursaid A, Jensen MM, Huo E, Ghandehari H. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. Controlled Release. 2016; 240: 414.
8. Ghouri Y, Mian I, Rowe J. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. Carcinog. 2017; 16: 1.
9. Doyon D, Mouzon A, Jourde AM, Regensberg C, Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours. Ann. Radiol. 1974; 17: 593.
10. Raymond J, et al. Hydrogel versus Bare Platinum Coils in Patients with Large or Recurrent Aneurysms Prone to Recurrence after Endovascular Treatment: A Randomized Controlled Trial. Am. J. Neuroradiol. 2017; 38: 432.
11. Slesnick TC, et al. Valente Safety of Magnetic Resonance Imaging After Implantation of Stainless Steel Embolization Coils, Pediatr. Cardiol. 2016; 37: 62.
12. Wang W, Zhang YY, Liu WG. Controllable Synthesis of Fluorescent Carbon Dots and Their Detection Application as Nanoprobes, Prog. Polym. Sci. 2017; 71: 1.
13. Bannerman D, Wan WK. Multifunctional microbeads for drug delivery in TACE, Expert Opin. Drug Delivery. 2016; 13: 1289.
14. Hasan MS, Kehoe S, Boyd D. Temporal analysis of dissolution by-products and genotoxic potential of spherical zinc–silicate bioglass: “Imageable beads” for transarterial embolization. J. Biomater. Appl. 2014; 29: 566.
15. Ladner TR, et al. Mocco Septoplasty: Scepter Balloon Angioplasty for Vasospasm after Aneurysmal Subarachnoid Hemorrhage, J. Neurointerv. Surg. 2016; 8: 210.
16. Dolgushin BI, Kosyrev VYU, Martynkov DV, Demidov LV, SHishkina NA, Utyashev IA, Nazarova VV. Transarterial chemoembolization for liver metastases of uveal melanoma. Vestnik rentgenologii i radiologii. 2016; 97(4): 215-223. (In Russ).
17. Kaprin AD, Ivanov SA, Kucherov VV, Petrosyan AP, Majorov KV, Markov NV, Petrov LO, Davydov GA, Sigov MA, Silant’eva NK, Berezovskaya TP, Usacheva AYU, Sanin DB. Radioembolization of the liver: a new chapter in domestic oncology. Russian journal of gastroenterology, hepatology, coloproctology. 2019; 29(5): 7-12. (In Russ).
18. The state of oncological care for the population of Russia in 2017. Ed. A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: MNIOI im. P.A. Herzen, 2018 (In Russ).
19. Reinders MTM, Mees E, Powerski MJ, et al. Radio-embolisation in Europe: A Survey Amongst CIRSE Mem-bers. Cardiovasc. Intervent. Radiol. 2018; 41: 1579.
20. Yakovec EA, Nejmark AI, Karpenko AA, Yakovec YAV. Embolization of prostate arteries in the treatment of patients with prostate adenoma with high surgical risk. 2010; 1: 38-43. (In Russ).
21. Amouyal G, Thiounn N, Pellerin O et al Clinical results after prostatic artery embolisation using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol. 2016, 39: 367-375.
22. Nejmark AI, Tachalov MA, Nejmark BA, Torbik DV, Arzamascev DD. Interventional surgery in the treatment of patients with benign hyperplasia and prostate cancer. Vestnik Urologii. 2015; 3: 54-67. (In Russ).
23. Alyaev YUG, Sorokin NI, Kondrashin SA, SHpot’ EV, Sirota ES. Superselective embolization of tumor-feeding vessels before kidney resection. Vestnik Urologii. 2016; 2: 13-28. (In Russ).
24. Krasulin V.V., Gluhov V.P., Vasil’ev K.S. Modern possibilities of surgical treatment of prostatic hyperplasia. Vestnik Urologii. 2019;7(2):85-92. (In Russ).
25. Torbik DV. Superselective embolization of the arteries of the prostate gland with its large hyperplasia. 2018. (In Russ).
26. Na R, Helfand BT, Chen H, Conran CA, Crawford SE, Hayward SW, Tammela T, Hoff man-Bolton J, Zheng SL, Walsh PC, Schleutker J, Platz EA, Isaacs WB, Xu J. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Prostate. 2017; 77: 1213-1220. doi: 10.1002/ pros.23380.
27. Khanaliev BV, Nesterov SN, Barsegyan AG. Transurethral resection of the prostate in a patient with long-term lower urinary tract syndrome. Bulletin of Pirogov National Medical and Surgical Center named. 2020; 15(1). (In Russ).
28. Eric M. Bortnick MD, VannitaSimma-Chiang MD, Steven A. Kaplan MD. Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia Rev Urol. 2019; 21(4): 154-157.
29. Qian X, Liu H, Xu D, Xu L, Huang F, He W, Qi J, Zhu Y, Xu D. Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and meta-analysis. Aging Male. 2017; 20(3): 184-191. doi: 10.1080/13685538.2017.1295436.
30. Pushkar’ DYU, Bernikov AN, Hodyreva LA, Dudareva AA, Al’-SHukri SH, Amdij RE, Aboyan IA, SHiranov KA, Medvedev VL, Efremov ME. Quality of life in patients with lower urinary tract symptoms after TURP for BPH. Urology. 2018. (In Russ).
31. Barsegyan AG. Quality of life of patients with diseases of the genitourinary system when using endovideosurgical methods of treatment. 2020. (In Russ).
32. Pisco JM, Bilhim T, Pinheiro LC et al. Medium-and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J VascIntervRadiol. 2016; 27: 1115-22.
33. Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED Technique”: proximal embolisation first, then embolise distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014; 37: 1602-5.
34. Nejmark AI, Yakovec EA, YAkovec YAV, Arzamascev DD. Evaluation of the effectiveness of X-ray endovascular embolization of arteries in BPH using transrectal Doppler ultrasonography: Proceedings of the International Congress on Andrology. Andrology and genital surgery. 2009; 2: 117-128. (In Russ).
35. Yakovets EA, Neimark AI, Karpenko AA, Yakovets YaV. Embolization of prostate arteries in the treatment of patients with prostate adenoma with high surgical risk. 2010; 1: 38-43 (In Russ).
36. Kurbatov DG, Dubsky SA, Sitkin II, Lepetukhin AE. X-ray endovascular occlusion of the arteries of the prostate — an alternative innovative method for the treatment of patients with large prostate adenoma. Urology. 2013; 2: 28-53. (In Russ).
37. George Camara-Lopes, et al. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia. IntBraz J Urol. 2013; 39(2): 222-7.
38. Zhukov OB, Ukolov VA, Shcherbinin SN, Snitkin VM. Algorithm for the management of patients with endovascular embolization of prostate arteries in its benign hyperplasia. Andrology and genital surgery. 2016; 2: 68-76. (In Russ).
39. Bagla S, Martin CP, van Breda A, et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J. Vasc. Interv. Radiol. 2014; 25: 47-52.
40. Maclean D, Harris M, Bryant T, et al. Factors Predicting a Good Symptomatic Outcome After Prostate Artery Embolisation (PAE). Cardiovascular and Interventional Radiology. 2018 Feb; 26.
41. Somani BK, Hacking N, Bryant T, et al. Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH). BJU Int. 2014; 114: 639-640.
42. Wang M, Guo L, Duan F, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large- volume prostates. BJU Int. 2016; 117: 155-164.
43. Grosso M, Balderi A, Arno M, et al. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients. Radiol. Med. 2015; 120: 361-368.
44. Lebdai S, Delongchamps NB, Sapoval M, et al. Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia. World Journal Of Urology. 2016; 34(5): 625-632.
45. Teichgräber U, Aschenbach R, Diamantis I, von Rundstedt F-C, Grimm M-O, Franiel T. Prostate Artery Embolization: Indication, Technique and Clinical Results. RöFo — Fortschritte Auf Dem Gebiet Der Röntgenstrahlen Und Der BildgebendenVerfahren. 2018. doi:10.1055/a-0612-8067.
46. Shim SR, Kanhai KJ, Ko YM, et al. Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression.JUrol. 2017; 197: 465-479.
47. Uflacker A, Haskal ZJ, Bilhim T, et al. Meta-Analysis of Prostatic Artery Embolization for Benign Prostatic Hyperplasia. J VascIntervRadiol 2016; 27: 1686-1697. e1688.
48. Lebdai S, Delongchamps NB, Sapoval M, et al. Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia. World Journal Of Urology. 2016;34(5): 625-632.
